Oct 28
Earnings call
Q2 2027 earnings call
Concord Biotech Limited reported H1 FY27 revenue of 566.6 crores, up 26%, and PAT of 127.3 crores, up 19%, with EBITDA margin of 33%. Cash and cash equivalents were around 445 crores as of September 30, 2026.